FibroGen, Inc. (FGEN)
8.82
+0.32
(+3.70%)
USD |
NASDAQ |
Dec 10, 16:00
8.82
0.00 (0.00%)
After-Hours: 06:02
FibroGen Free Cash Flow: -17.14M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Assertio Holdings, Inc. | 13.33M |
| Perspective Therapeutics, Inc. | -106.85M |
| Skye Bioscience, Inc. | -41.53M |
| Theravance Biopharma, Inc. | 243.48M |
| Myomo, Inc. | -13.85M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -1.847M |
| Cash from Investing (Quarterly) | 87.16M |
| Cash from Financing (Quarterly) | -85.92M |
| Free Cash Flow Per Share (Quarterly) | -0.459 |
| Free Cash Flow to Equity (Quarterly) | 70.24M |
| Free Cash Flow to Firm (Quarterly) | 0.227M |
| Free Cash Flow Yield | -6.87% |